|
|
||||||||
1 Laboratoire de Physiologie Cellulaire, INSERM EMI 0228, Bâtiment SN3, Université des Sciences et Technologies de Lille, 59655 Villeneuve dAscq Cedex, France
2 Institut Andre Lwoff, Centre National de la Recherche Scientifique, UPR 9079, Villejuif, F-94801 France
3 INSERM, U-407, Communications Cellulaires en Biologie de la Reproduction, Faculté de Medecine Lyon-Sud, Oullins Cedex, BP 12, F-69921 France
(Requests for offprints should be addressed to N Prevarskaya; Email: phycel{at}univ-lille1.fr)
TRPM8 (melastatine-related transient receptor potential member 8), a member of the transient receptor potential (TRP) superfamily of cation channels, has been shown to be a calcium-channel protein. TRPM8 mRNA has also been shown to be overexpressed in prostate cancer and is considered to play an important role in prostate physiology. This study was designed to determine the androgen-regulation mechanisms for TRPM8 mRNA expression and to identify the phenotype of TRPM8-expressing cells in the human prostate. Our findings show that trpm8 gene expression requires a functional androgen receptor. Furthermore, this article argues strongly in favour of the fact that the trpm8 gene is a primary androgen-responsive gene. Single-cell reverse transcriptase PCR and immunohistochemical experiments also showed that the trpm8 gene was mainly expressed in the apical secretory epithelial cells of the human prostate and trpm8 down-regulation occurred during the loss of the apical differentiated phenotype of the primary cultured human prostate epithelial cells. The androgen-regulated trpm8 expression mechanisms are important in understanding the progression of prostate cancer to androgen-independence. These findings may contribute to design a strategy to predict prostate cancer status from the TRPM8 mRNA level. Furthermore, as the TRPM8 channel is localized in human prostate cells, it will be interesting to understand its physiological function in the normal prostate and its potential role in prostate cancer development.
This article has been cited by other articles:
![]() |
M. Monet, V. Lehen'kyi, F. Gackiere, V. Firlej, M. Vandenberghe, M. Roudbaraki, D. Gkika, A. Pourtier, G. Bidaux, C. Slomianny, et al. Role of Cationic Channel TRPV2 in Promoting Prostate Cancer Migration and Progression to Androgen Resistance Cancer Res., February 1, 2010; 70(3): 1225 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Sabnis, M. Shadid, G. S. Yost, and C. A. Reilly Human Lung Epithelial Cells Express a Functional Cold-Sensing TRPM8 Variant Am. J. Respir. Cell Mol. Biol., October 1, 2008; 39(4): 466 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gackiere, G. Bidaux, P. Delcourt, F. Van Coppenolle, M. Katsogiannou, E. Dewailly, A. Bavencoffe, M. T. Van Chuoi-Mariot, B. Mauroy, N. Prevarskaya, et al. CaV3.2 T-type Calcium Channels Are Involved in Calcium-dependent Secretion of Neuroendocrine Prostate Cancer Cells J. Biol. Chem., April 11, 2008; 283(15): 10162 - 10173. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang, Q. Tong, K. Conrad, J. Wozney, J. Y. Cheung, and B. A. Miller Regulation of TRP channel TRPM2 by the tyrosine phosphatase PTPL1 Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1746 - C1758. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kiselyov, A. Soyombo, and S. Muallem TRPpathies J. Physiol., February 1, 2007; 578(3): 641 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang and G. J Barritt TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function? Endocr. Relat. Cancer, March 1, 2006; 13(1): 27 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Thebault, L. Lemonnier, G. Bidaux, M. Flourakis, A. Bavencoffe, D. Gordienko, M. Roudbaraki, P. Delcourt, Y. Panchin, Y. Shuba, et al. Novel Role of Cold/Menthol-sensitive Transient Receptor Potential Melastatine Family Member 8 (TRPM8) in the Activation of Store-operated Channels in LNCaP Human Prostate Cancer Epithelial Cells J. Biol. Chem., November 25, 2005; 280(47): 39423 - 39435. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |